Neurocrine Biosciences Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +17.8% | -12.4% | +35.7% | +70.3% | +86.2% | -23.0% | +108.2% | -6.4% | -7.0% | -19.3% | -29.0% | -57.3% | -40.1% | +103.9% | -4.2% | +41.6% | -21.1% | +57.1% | +95.4% | -23.1% | +123.9% | +21.5% | +31.5% | +32.8% | +19.5% | +14.3% | +37.3% | +14.4% | +24.5% | |
| – | +6.0% | -14.1% | +44.5% | +81.9% | +92.3% | -25.2% | +90.2% | -33.5% | -11.0% | -30.7% | -5.5% | -55.5% | -32.0% | +140.2% | -0.4% | +42.9% | -21.6% | +33.5% | +93.8% | -19.2% | +78.8% | +33.0% | +12.6% | +22.3% | -4.3% | +49.4% | +10.6% | +7.3% | +46.3% | |
| – | +39.8% | -25.9% | +82.1% | -1.0% | +677.5% | -73.0% | +138.9% | -42.3% | -18.2% | +62.1% | +23.1% | -31.3% | -45.5% | +44.8% | -7.3% | +27.2% | -29.7% | -30.8% | +139.2% | +12.2% | +205.9% | -44.4% | -20.8% | +66.6% | +82.1% | -22.9% | -4.5% | -7.2% | +206.0% | |
| – | +39.8% | -25.9% | +678.6% | +80.8% | +94.3% | -23.5% | +85.2% | -33.6% | -9.3% | -33.1% | -1.8% | -55.1% | -33.6% | +137.3% | +1.8% | +34.0% | -15.8% | +33.0% | +95.7% | -18.9% | +67.9% | +26.2% | +3.0% | +19.5% | -11.2% | +39.1% | +4.3% | +4.3% | +37.6% | |
| – | -84.6% | +600.0% | +7.1% | +298.3% | +66.5% | -97.5% | +5,430.0% | -39.9% | -89.6% | +738.1% | -99.6% | +44.4% | – | – | -57.4% | +640.4% | -99.8% | – | – | – | – | +80.7% | +125.1% | +24.1% | +18.1% | +88.7% | +25.5% | +9.1% | +43.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +59.1% | +62.0% | +8.9% | +15.1% | +9.1% | +49.9% | +20.2% | |
| – | – | – | – | – | +7.0% | +16.7% | +298.8% | +81.7% | -2.8% | -8.0% | -9.6% | -92.5% | -56.5% | -43.2% | +3.5% | +19.8% | -6.8% | +41.6% | +36.9% | +82.7% | +72.4% | +213.3% | +23.8% | +6.4% | +31.4% | +0.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +7.4% | -1.7% | – | |
| – | -14.3% | -16.7% | -40.0% | -39.7% | -48.1% | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | +11.7% | – | – | – | -4.6% | +2.8% | – | |
| – | +67.3% | -2.3% | +50.6% | +77.8% | +58.0% | +17.6% | +287.5% | -23.5% | -25.8% | -19.4% | +110.7% | -48.5% | -17.9% | +87.1% | -37.4% | -46.9% | -17.6% | +0.2% | +46.6% | -0.2% | +787.2% | +15.0% | +30.6% | -9.1% | +14.8% | -5.4% | +54.2% | +10.8% | +22.1% | |
| – | +80.5% | -24.3% | +53.6% | +73.9% | +65.5% | +31.2% | +238.7% | -45.8% | -43.5% | -40.3% | +48.7% | -12.7% | -23.5% | +164.4% | -10.7% | -66.8% | -25.2% | +33.9% | +64.2% | +18.3% | +79.0% | +62.1% | +540.7% | -67.0% | +31.8% | +118.8% | +21.8% | -22.5% | +46.4% | |
| – | +12.5% | -11.1% | +25.0% | +58.7% | +31.5% | +27.4% | +49.0% | +68.5% | -12.9% | -22.8% | -66.9% | +429.6% | -45.5% | +100.6% | -1.8% | +32.8% | – | – | – | +18.9% | +158.2% | +62.5% | +555.7% | -97.5% | +60.2% | +926.7% | +0.4% | – | – | |
| – | +125.0% | +38.9% | -4.0% | -55.6% | +44.5% | +27.3% | -33.9% | +316.3% | +295.9% | -84.9% | +17.5% | -57.7% | +36.8% | -63.0% | +37.2% | -18.0% | -88.9% | +143.6% | +941.1% | +98.6% | +11.1% | +144.4% | +234.9% | -14.7% | +30.7% | +30.7% | +98.1% | -25.1% | +5.0% | |
| – | – | – | – | – | +57.7% | +46.6% | +515.4% | +83.1% | -9.9% | -8.3% | +121.2% | – | – | – | – | – | – | – | – | – | – | +5.1% | +5.2% | -22.2% | +5.4% | – | – | – | – | |
| – | +14.3% | -13.5% | +33.9% | +69.3% | +90.2% | -27.8% | +74.4% | +0.7% | -0.9% | -19.3% | -62.3% | -69.0% | -89.2% | +389.3% | +210.6% | +156.9% | -22.0% | +73.3% | +103.4% | -25.8% | +18.2% | +29.2% | +32.5% | +76.8% | +22.0% | +24.3% | +30.7% | +16.0% | +25.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +1,433.2% | |
| – | +11.1% | -0.4% | +5.1% | +16.0% | +17.6% | +17.1% | +6.2% | +11.8% | +4.9% | -0.7% | +0.8% | +1.2% | +1.8% | +35.0% | +6.7% | +18.8% | +0.1% | +11.3% | +13.3% | +2.6% | +1.6% | +8.3% | +0.3% | +2.2% | +0.1% | +1.0% | +2.1% | +2.7% | -1.2% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.